Authors:
Gaborjan, A
Halmos, G
Repassy, G
Vizi, ES
Citation: A. Gaborjan et al., A new aspect of aminoglycoside ototoxicity: impairment of cochlear dopamine release, NEUROREPORT, 12(15), 2001, pp. 3327-3330
Authors:
Lukits, J
Timar, J
Juhasz, A
Dome, B
Paku, S
Repassy, G
Citation: J. Lukits et al., Progression difference between cancers of the larynx and hypopharynx is not due to tumor size and vascularization, OTO H N SUR, 125(1), 2001, pp. 18-22
Citation: O. Ribari et al., New method for inserting and fixing the active electrode during cochlear implantation, ACT OTO-LAR, 121(2), 2001, pp. 194-196
Authors:
Tamas, L
Kraxner, H
Mechtler, L
Repassy, G
Ribari, O
Hirschberg, A
Szentkuti, G
Jaray, B
Szentirmay, Z
Citation: L. Tamas et al., Prognostic significance of p53 histochemistry and DNA histogram parametersin head and neck malignancies, ANTICANC R, 20(5C), 2000, pp. 4031-4037
Citation: A. Juhasz et al., Characteristic distribution patterns of tenascin in laryngeal and hypopharyngeal cancers, LARYNGOSCOP, 110(1), 2000, pp. 84-92
Citation: L. Toth et al., Electronystagmographic analysis of optokinetic nystagmus for the evaluation of ocular symptoms in myasthenia gravis, ACT OTO-LAR, 119(6), 1999, pp. 629-632
Authors:
Ribari, O
Kustel, M
Szirmai, A
Repassy, G
Citation: O. Ribari et al., Cochlear implantation influences contralateral hearing and vestibular responsiveness, ACT OTO-LAR, 119(2), 1999, pp. 225-228
Authors:
Toth, L
Racz, T
Dioszeghy, P
Repassy, G
Lampe, I
Citation: L. Toth et al., Otoacoustic emission in myasthenia gravis patients and the role of efferent activation, HEARING RES, 126(1-2), 1998, pp. 123-125